JP Morgan 2024

R&D
Jonah Comstock and Frank Gleeson at JP Morgan

JP Morgan 2024 – Frank Gleeson

In this brief dispatch from JP Morgan, Editor in Chief Jonah Comstock grabs a few minutes with Frank Gleeson, CEO of Satellos Bioscience. 

R&D
JP Morgan 2024 – Jen Nwankwo

JP Morgan 2024 – Jen Nwankwo

While 2023 may have been the year of AI for the consumer consciousness, for companies using the technology in a focused way in drug development it was just another year of learning and adva

R&D
JP Morgan 2024 – Graham Heap

JP Morgan 2024 – Graham Heap

Just over a year ago, Takeda acquired a promising immunotherapy candidate, TAK-279, from Boston-based Nimbus Therapeutics.

Digital
pharmaphorum podcast episode 109

Key themes from JP Morgan

pharmaphorum editor-in-chief Jonah Comstock is back from San Francisco, where he attended the annual JP Morgan Healthcare Conference.

R&D
JP Morgan 2024 – Jeff Smith

JP Morgan 2024 – Jeff Smith

Editor-in-chief Jonah Comstock sat down with Jeff Smith, chief research officer at Precision BioSciences, on the side lines of the JP Morgan Healthcare Conference in San Francisco to discus